University of Cagliari
reserved
The endocannabinoid system: a new molecular target for the treatment of tobacco addiction
SCHERMA, MARIA;FADDA, PAOLA;FRATTA, WALTER;
2008-01-01
Abstract
Tobacco addiction is one of the leading preventable causes of mortality in the world and nicotine appears to be the main critical psychoactive component in establishing and maintaining tobacco dependence. Several lines of evidence suggest that the rewarding effects of nicotine, which underlie its abuse potential, can be modulated by manipulating the endocannabinoid system. For example, pharmacological blockade or genetic deletion of cannabinoid CB(1) receptors reduces or eliminates many behavioral and neurochemical effects of nicotine that are related to its addictive potential. This review will focus on the recently published literature about the role of the endocannabinoid system in nicotine addiction and on the endocannabinoid system as a novel molecular target for the discovery of medications for tobacco dependence.
Files in This Item:
| File | Size | Format | |
|---|---|---|---|
| Scherma et al CNS & Neur Dis Drug Targets 2008.pdf Solo gestori archivio
Type: versione editoriale
Size 255.92 kB
Format Adobe PDF
|
255.92 kB | Adobe PDF | & nbsp; View / Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.